In vivo NKTT320-induced activation of invariant Natural Killer T-cells (iNKTs) and potential applications for use in AIDS pathogenesis modulation

被引：0
|
作者：
Bond, Nell G. [1 ]
Yu, Shan [1 ]
Rout, Namita [1 ]
Tran, Dollnovan [1 ]
Szeltner, Dawn [1 ]
Schaub, Robert [2 ]
Kaur, Amitinder [1 ]
机构：
[1] Tulane Univ, New Orleans, LA 70118 USA
[2] NKT Therapeut, Waltham, MA USA
来源：
JOURNAL OF IMMUNOLOGY | 2018年 / 200卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
180.9
引用
收藏
页数：3
相关论文
共 30 条
  • [1] NKTT320-induced activation of invariant Natural Killer T-cells (iNKTs) in vivo and implication for its use in modulating AIDS pathogenesis
    Bondi, Nell
    Yu, Shan
    Rout, Namita
    Tran, Dollnovan
    Szeltner, Dawn
    Schaub, Robert
    Kaur, Amitinder
    [J]. JOURNAL OF MEDICAL PRIMATOLOGY, 2018, 47 (05) : 330 - 330
  • [2] Activation mechanisms of invariant natural killer T cells (iNKTs)
    Baena, Andres
    Gomez-Giraldo, Lina
    Carreno, Leandro J.
    [J]. IATREIA, 2016, 29 (01) : 51 - 64
  • [3] Immunomodulatory potential of in vivo natural killer T (NKT) activation by NKTT320 in Mauritian-origin cynomolgus macaques
    Bond, Nell G.
    Fahlberg, Marissa D.
    Yu, Shan
    Rout, Namita
    Tran, Dollnovan
    Fitzpatrick-Schmidt, Taylor
    Sprehe, Lesli M.
    Scheef, Elizabeth A.
    Mudd, Joseph C.
    Schaub, Robert
    Kaur, Amitinder
    [J]. ISCIENCE, 2022, 25 (03)
  • [4] Activation of invariant natural killer T-cells in periodontitis lesions
    Nowak, M.
    Kraemer, B.
    Haupt, M.
    Papapanou, P. N.
    Kebschull, J.
    Hoffmann, P.
    Jepsen, S.
    Perner, S.
    Schmidt-Wolf, I. G. H.
    Kebschull, M.
    [J]. IMMUNOLOGY, 2012, 137 : 465 - 465
  • [5] Cancer Immunotherapeutic Potential of NKTT320, a Novel, Invariant, Natural Killer T Cell-Activating, Humanized Monoclonal Antibody
    Patel, Nishant P.
    Guan, Peng
    Bahal, Devika
    Hashem, Tanwir
    Scheuplein, Felix
    Schaub, Robert
    Nichols, Kim E.
    Das, Rupali
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) : 1 - 17
  • [6] Cancer immunotherapeutic potential of NKTT320, a novel human invariant natural killer T-cell activating monoclonal antibody
    Das, Rupali
    Scheuplein, Felix
    Guan, Peng
    Schaub, Robert
    Nichols, Kim E.
    [J]. CANCER RESEARCH, 2015, 75
  • [7] NKTT320, a novel monoclonal antibody activates the immuno-stimulatory functions of human invariant natural killer T cells
    Das, Rupali
    Scheuplein, Felix
    Patel, Nishant P.
    Guan, Peng
    Schaub, Robert G.
    Nichols, Kim E.
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [8] Invariant Natural Killer T-cells and their subtypes may play a role in the pathogenesis of endometriosis
    Correa, Frederico J. S.
    Andres, Marina Paula
    Rocha, Taina Pezzin
    Carvalho, Ana Eduarda Z.
    Aloia, Thiago P. A.
    Corpa, Marcus V. N.
    Kallas, Esper G.
    Mangueira, Cristovao L. P.
    Baracat, Edmund C.
    Carvalho, Karina, I
    Abrao, Mauricio S.
    [J]. CLINICS, 2022, 77
  • [9] Activation of Invariant Natural Killer T Cells Ameliorates Doxorubicin-Induced Cardiomyopathy
    Sada, Masashi
    Matsushima, Shouji
    Ikeda, Soichiro
    Okabe, Kosuke
    Ishikita, Akihito
    Tadokoro, Tomonori
    Enzan, Nobuyuki
    Yamamoto, Taishi
    Deguchi, Hiroko
    Ikeda, Masataka
    Ide, Tomomi
    Tsutsui, Hiroyuki
    [J]. CIRCULATION, 2019, 140
  • [10] Activation of invariant natural killer T cells ameliorates doxorubicin-induced cardiomyopathy
    Sada, M.
    Matsushima, S.
    Ikeda, S.
    Okabe, K.
    Ishikita, A.
    Tadokoro, T.
    Enzan, N.
    Yamamoto, T.
    Deguchi, Y.
    Ikeda, M.
    Ide, T.
    Tsutsui, H.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 3908 - 3908
123